Screener
D&A at other companies
Other financials
Where this comes from
Reported directly by Kestra Medical Technologies in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The source filing: Kestra Medical Technologies’s 10-K, filed July 14, 2026. Open the filing →
- Filed
- Jul 14, 2026, 5:16 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001193125-26-303397
FAQ
- What is Kestra Medical Technologies's D&A?
- Kestra Medical Technologies (KMTS) reported D&A of $2.33M in Q1 2026.
- How has Kestra Medical Technologies's D&A changed year-over-year?
- Kestra Medical Technologies's D&A increased by 26.6% year-over-year, from $1.84M to $2.33M.
- What is the long-term trend for Kestra Medical Technologies's D&A?
- Over 2 years (2024 to 2026), Kestra Medical Technologies's D&A has grown at a -13.2% compound annual growth rate (CAGR), from $11.56M to $8.71M.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.
Ask your AI about Kestra Medical Technologies's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude